Zotarolimus- versus sirolimus- versus paclitaxel-eluting stents for the prevention of coronary artery restenosis in patients with acute coronary syndromes or stable angina undergoing percutaneous coronary intervention

Trial Profile

Zotarolimus- versus sirolimus- versus paclitaxel-eluting stents for the prevention of coronary artery restenosis in patients with acute coronary syndromes or stable angina undergoing percutaneous coronary intervention

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Aug 2012

At a glance

  • Drugs Zotarolimus (Primary) ; Paclitaxel; Sirolimus
  • Indications Acute coronary syndromes; Angina pectoris; Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms ZEST
  • Most Recent Events

    • 11 Nov 2011 Serial angiographic follow-up results presented at the 23rd Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.
    • 23 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top